620 KRW
10.76 B KRW
72.43 B KRW
8.33 M
About OPTUS PHARMACEUTICAL
Sector
CEO
Eun-Young Park
Headquarters
Cheongju-si
Website
Founded
2010
ISIN
KR7131030009
FIGI
BBG0018D6WC0
OPTUS Pharmaceutical Co., Ltd. engages in the manufacture and sale of ophthalmic products. Its products include artificial tears, eye drops, antibiotic ophthalmic solutions, and ethyl chloride spray. The company was founded on July 27, 2010 and is headquartered in Cheongju-si, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 131030 is 6,520 KRW — it has decreased by −14.23% in the past 24 hours. Watch OPTUS PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange OPTUS PHARMACEUTICAL stocks are traded under the ticker 131030.
131030 stock has risen by 10.58% compared to the previous week, the month change is a 14.42% rise, over the last year OPTUS PHARMACEUTICAL has showed a 26.60% increase.
131030 reached its all-time high on Feb 5, 2015 with the price of 17,600 KRW, and its all-time low was 3,210 KRW and was reached on Sep 26, 2011. View more price dynamics on 131030 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
131030 stock is 7.87% volatile and has beta coefficient of 1.23. Track OPTUS PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is OPTUS PHARMACEUTICAL there?
Today OPTUS PHARMACEUTICAL has the market capitalization of 95.77 B, it has increased by 26.03% over the last week.
Yes, you can track OPTUS PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
131030 net income for the last quarter is 1.52 B KRW, while the quarter before that showed 2.42 B KRW of net income which accounts for −37.30% change. Track more OPTUS PHARMACEUTICAL financial stats to get the full picture.
Yes, 131030 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.59%. Tracking OPTUS PHARMACEUTICAL dividends might help you take more informed decisions.
OPTUS PHARMACEUTICAL dividend yield was 1.88% in 2023, and payout ratio reached 14.12%. The year before the numbers were 1.59% and 31.67% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has 204.00 employees. See our rating of the largest employees — is OPTUS PHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. OPTUS PHARMACEUTICAL EBITDA is 11.37 B KRW, and current EBITDA margin is 17.15%. See more stats in OPTUS PHARMACEUTICAL financial statements.
Like other stocks, 131030 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade OPTUS PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So OPTUS PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating OPTUS PHARMACEUTICAL stock shows the neutral signal. See more of OPTUS PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.